Literature DB >> 2474671

Transcription-inhibition and RNA-binding domains of influenza A virus matrix protein mapped with anti-idiotypic antibodies and synthetic peptides.

Z P Ye1, N W Baylor, R R Wagner.   

Abstract

We have undertaken by biochemical and immunological experiments to locate the region of the matrix (M1) protein responsible for down-regulating endogenous transcription of A/WSN/33 influenza virus. A more refined map of the antigenic determinants of the M1 protein was obtained by binding of epitope-specific monoclonal antibodies (MAbs) to chemically cleaved fragments. Epitope 2-specific MAb 289/4 and MAb 7E5 reverse transcription inhibition by M1 protein and react with a 4-kilodalton cyanogen bromide fragment extending from amino acid Gly-129 to Gln-164. Anti-idiotype serum immunoglobulin G prepared in rabbits immunized with MAb 289/4 or MAb 7E5 mimicked the action of M1 protein by inhibiting transcription in vitro of influenza virus ribonucleoprotein cores. This transcription-inhibition activity of anti-MAb 7E5 immunoglobulin G and anti-MAb 289/4 immunoglobulin G could be reversed by MAb 7E5 and MAb 289/4 or could be removed by MAb 7E5-Sepharose affinity chromatography. Transcription of influenza virus ribonucleoprotein was inhibited by one of three synthetic oligopeptides, a nonodecapeptide SP3 with an amino acid sequence corresponding to Pro-90 through Thr-108 of the M1 protein. Of all the structural proteins of influenza virus, only NP and M1 showed strong affinity for binding viral RNA or other extraneous RNAs. The 4-kilodalton cyanogen bromide peptide (Gly-129 to Gln-164), exhibited marked affinity for viral RNA, the binding of which was blocked by epitope 2-specific MAb 7E5 but not by MAbs directed to three other epitopes. Viral RNA also bound strongly to the nonodecapeptide SP3 and rather less well to anti-idiotype anti-MAb 7E5; these latter viral RNA-binding reactions were only slightly blocked by preincubation of anti-MAb 7E5 or SP3 with MAb 7E5. These experiments suggest the presence of at least two RNA-binding sites, which also serve as transcription-inhibition sites, centered around amino acid sequences 80 through 109 (epitope 4?) and 129 through 164 (epitope 2) of the 252 amino acid M1 protein of A/WSN/33 influenza virus. A hydropathy plot of the M1 protein calculated by free-energy transfer suggests that the two hydrophilic transcription-inhibition RNA-binding domains are brought into close proximity by an alpha-helix-forming intervening hydrophobic domain.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2474671      PMCID: PMC250948     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  21 in total

Review 1.  Idiotypic mimicry of biological receptors.

Authors:  G N Gaulton; M I Greene
Journal:  Annu Rev Immunol       Date:  1986       Impact factor: 28.527

2.  Mapping regions of the matrix protein of vesicular stomatitis virus which bind to ribonucleocapsids, liposomes, and monoclonal antibodies.

Authors:  J R Ogden; R Pal; R R Wagner
Journal:  J Virol       Date:  1986-06       Impact factor: 5.103

3.  Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface.

Authors:  R A Lamb; S L Zebedee; C D Richardson
Journal:  Cell       Date:  1985-03       Impact factor: 41.582

4.  Implications of the presence of an internal image of the antigen in anti-idiotypic antibodies: possible application to vaccine production.

Authors:  A Nisonoff; E Lamoyi
Journal:  Clin Immunol Immunopathol       Date:  1981-12

5.  Influenza virus RNA segment 7 has the coding capacity for two polypeptides.

Authors:  H Allen; J McCauley; M Waterfield; M J Gething
Journal:  Virology       Date:  1980-12       Impact factor: 3.616

Review 6.  The gene structure and replication of influenza virus.

Authors:  R A Lamb; P W Choppin
Journal:  Annu Rev Biochem       Date:  1983       Impact factor: 23.643

7.  Influence of membrane (M) protein on influenza A virus virion transcriptase activity in vitro and its susceptibility to rimantadine.

Authors:  A Y Zvonarjev; Y Z Ghendon
Journal:  J Virol       Date:  1980-02       Impact factor: 5.103

8.  Antigenic characterization of influenza A virus matrix protein with monoclonal antibodies.

Authors:  K L van Wyke; J W Yewdell; L J Reck; B R Murphy
Journal:  J Virol       Date:  1984-01       Impact factor: 5.103

9.  Insertion of influenza M protein into the viral lipid bilayer and localization of site of insertion.

Authors:  A Gregoriades; B Frangione
Journal:  J Virol       Date:  1981-10       Impact factor: 5.103

10.  Interaction of influenza M protein with viral lipid and phosphatidylcholine vesicles.

Authors:  A Gregoriades
Journal:  J Virol       Date:  1980-11       Impact factor: 5.103

View more
  45 in total

1.  Restriction of viral replication by mutation of the influenza virus matrix protein.

Authors:  Teresa Liu; Zhiping Ye
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

2.  Characterization of the antiviral activity for influenza viruses M1 zinc finger peptides.

Authors:  Yongjin Wang; Huihui Xiao; Nannan Wu; Huiling Shi; Hongwei Xu; Lichen Zhou; Xu-Guang Xi; Tianhou Wang; Xiaoming Wang
Journal:  Curr Microbiol       Date:  2010-06-05       Impact factor: 2.188

Review 3.  A selective review of RNA-protein interactions in eukaryotes.

Authors:  I W Mattaj
Journal:  Mol Biol Rep       Date:  1990       Impact factor: 2.316

4.  Structure-based design of NS2 mutants for attenuated influenza A virus vaccines.

Authors:  Hatice Akarsu; Kiyoko Iwatsuki-Horimoto; Takeshi Noda; Eiryo Kawakami; Hiroaki Katsura; Florence Baudin; Taisuke Horimoto; Yoshihiro Kawaoka
Journal:  Virus Res       Date:  2010-10-21       Impact factor: 3.303

5.  YRKL sequence of influenza virus M1 functions as the L domain motif and interacts with VPS28 and Cdc42.

Authors:  Eric Ka-Wai Hui; Subrata Barman; Dominic Ho-Ping Tang; Bryan France; Debi P Nayak
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

6.  Hyperphosphorylation of mutant influenza virus matrix protein, M1, causes its retention in the nucleus.

Authors:  G Whittaker; I Kemler; A Helenius
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

Review 7.  Development of universal influenza vaccines based on influenza virus M and NP genes.

Authors:  M Zheng; J Luo; Z Chen
Journal:  Infection       Date:  2013-11-01       Impact factor: 3.553

8.  Introduction of a temperature-sensitive phenotype into influenza A/WSN/33 virus by altering the basic amino acid domain of influenza virus matrix protein.

Authors:  Teresa Liu; Zhiping Ye
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

9.  Rabies virus M protein expressed in Escherichia coli and its regulatory role in virion-associated transcriptase activity.

Authors:  Y Ito; A Nishizono; K Mannen; K Hiramatsu; K Mifune
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

10.  Nuclear retention of M1 protein in a temperature-sensitive mutant of influenza (A/WSN/33) virus does not affect nuclear export of viral ribonucleoproteins.

Authors:  O Rey; D P Nayak
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.